Skip to content

Clinical trials

Phase 2 Liver Cirrhosis, Biliary trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Cirrhosis, Biliary Phase: Phase 2 Country / region: Canada Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20111
20131
20152
20162
20173
20212
20223
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences3
Intercept Pharmaceuticals3
Mirum Pharmaceuticals, Inc.2
Calliditas Therapeutics AB1
Calliditas Therapeutics Suisse SA1
Enanta Pharmaceuticals, Inc1
Escient Pharmaceuticals, Inc1
GlaxoSmithKline1
Janssen Research & Development, LLC1
Kowa Research Institute, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Cirrhosis, Biliary17
Pruritus3
Cholangitis1
Cholangitis, Sclerosing1
Cholestasis1
Digestive System Diseases1
Fibrosis1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.